TGF-β1 production in inflammatory bowel disease: Differing production patterns in Crohn's disease and ulcerative colitis

Clinical and Experimental Immunology

Volumn 134, Issue 1, 2003, Pages 120-126

  Del Zotto, B ^a   Mumolo, G ^a,b   Pronio, A M ^c   Montesani, C ^c   Tersigni, R ^d   Boirivant, Monica ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Cytokines; Human; Inflammation; Mucosa; Tolerance suppression anergy

Indexed keywords

MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; GAMMA INTERFERON; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; INFLAMMATION; INTESTINE FLORA; LAMINA PROPRIA; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ULCERATIVE COLITIS; CELL CULTURE; COMPARATIVE STUDY; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; SECRETION;

ADULT; AGED; CELLS, CULTURED; COLITIS, ULCERATIVE; CROHN DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0141762545     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02250.x     Document Type: Article

References (36)

1. Khalil Nasreen. TGF-β: from latent to active. Microbes Infect 1999; 1:1255-63.
2. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998; 16:137-61.
3. Gorelik L, Flavell RA. Transforming growth factor-β in T cell biology. Nature Rev Immunol 2002; 2:46-53.
4. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997; 18:335-43.
5. Strober W, Kelsall B, Marth T. Oral tolerance. J Clin Immunol 1998; 81:1-30.
6. Fukaura H, Kent SC, Pietrusewicz MJ, Koury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996; 98:70-7.
7. Neurath M, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J Exp Med 1996; 183:2605-16.
8. + T cells. J Exp Med 1996; 183:2669-74.
9. + T cell down-regulation in human intestinal mucosa. J Immunol 1997; 158:3626-34.
10. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102:448-55.
11. Duchmann R, May E, Heike M, Knolle P, Neurath M, Meyer zum Bushenfelde KH. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans. Gut 1999; 44:812-8.
12. Bull DM, Bookman MA. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 1977; 59:966-74.
13. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70.
14. + T cells: IL-4 and IFN-γ have opposing effects, while TGF-β positively regulates its own production. J Immunol 1998; 160:5719-28.
15. Fais S, Capobianchi M, Pallone F et al. Spontaneous release of interferon γ by intestinal lamina propria lymphocytes in Crohn's disease: kinetics of in vitro response to interferon γ inducers. Gut 1991; 32:403-7.
16. Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT. Interleukin-2 and interferon-γ secreting T cells in normal and diseased human intestinal mucosa. Immunology 1993; 78:127-31.
17. Monteleone G, Biancone L, Marasco R et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 1997; 112:1169-78.
18. Parronchi P, Romagnani P, Annunziato F et al. Type 1 T-helper cell predominance and IL-12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150:823-32.
19. + T cells through a STAT6-independent mechanism. Eur J Immunol 2001; 31:3659-66.
20. Wilkinson KA, Aung H, Toossi Z. Modulation of transforming growth factor β-1 gene expression by IL-12. Scand J Immunol 2000; 52:271-7.
21. Hayashi H, S.Abdollah Y, Qiu J et al. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 1997; 89:1165-73.
22. Ulloa L, Doody J, Massaguè J. Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway. Nature 1999; 397:710-3.
23. Blanchette F, Day R, Dong W, Laprise MH, Dubois CM. TGFβ1 regulates gene expression of its own converting enzyme furin. J Clin Invest 1997; 99:1974-83.
24. Blanchette F, Rudd P, Grondin F, Attisano L, Dubois CM. Involvement of Smads in TGF-β1-induced furin (fur) transcription. J Cell Physiol 2001; 188:264-73.
25. Monteleone G, Kumberova A, Croft NM, McKenzie C, Steer HW, MacDonald TT. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J Clin Invest 2001; 108:601-9.
26. Bitzer M, von Gersdoff G, Liang D et al. A mechanism of suppression of TGF-β/SMAD signaling by NF-kB/RelA. Genes Dev 2000; 14:187-97.
27. Strober W, Kelsall B, Fuss I et al. Reciprocal IFN γ and TGFβ responses regulate the occurrence of mucosa inflammation. Immunol Today 1997; 18:61-4.
28. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-β secretion and T cell apoptosis. J Immunol 1996; 157:2348-57.
29. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors α and β in colonic mucosa in inflammatory bowel disease. Gastroenterology 1996; 110:975-84.
30. di Mola FF, Friess H, Schreuren A et al. Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease. Ann Surg 1999; 229:67-75.
31. Xian CJ, Xu X, Mardell CE et al. Site-specific changes in transforming growth factor-α and -β1 expression in colonic mucosa of adolescents with inflammatory bowel disease. Scand J Gastroenterol 1999; 34:591-600.
32. Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor β1 precursor by human furin convertase. J Biol Chem 1995; 270:10618-24.
33. Gorelik L, Fields PE, Flavell RA. Cutting edge. TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 2000; 165:4773-7.
34. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997; 89:587-96.
35. Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem 1997; 272:21597-603.
36. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis, a routine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188:1929-39.